400-81-07
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 0mg | ￥ NjǪǀťť | -- | > 10 | -- | -- | -- | -- | ￥ NjǪǀťť | - + |
| 100mg | ￥ ŘǪĭǀťť | -- | > 10 | -- | -- | ￥ ŘǪĭǀťť | - + | ||
| 0mg | ￥ ŘĊNjǀťť | -- | > 10 | 1 | -- | ￥ ŘĊNjǀťť | - + | ||
| 1g | ￥ Ģưťǀťť | -- | > 10 | -- | 1 | -- | ￥ Ģưťǀťť | - + | |
| g | ￥ ŘNjŘĊǀťť | -- | 8 | -- | -- | -- | -- | ￥ ŘNjŘĊǀťť | - + |
| 10g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 100g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
10.04
[1]. Bollard J, et al. Palbociclib (PD-0331), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut. 017 Jul;66(7):186-16.
[]. Fry DW, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0331 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther. 004 Nov;3(11):147-38.
[3]. Goel S, et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature. 017 Aug 4;48(7668):471-47.
[4]. Richard S Finn, et al. PD 0331, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res. 00;11():R77.
P60-P64-P70-P73-P80-P330-P01
GHS08,GHS0
13708 现货
￥ NjNjňǀťť -0mg
10777 货期咨询
￥ ňĢĢǀťť -mg
136140 货期咨询
108187 货期咨询
￥ ĢưĭNjǀťť -1g
136006 货期咨询
￥ ưťNjǀťť -0mg
13704 货期咨询
13703 货期咨询
160647 货期咨询
13707 货期咨询
136004 货期咨询
沪ICP备170164号
